10x Genomics TXG reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
10x Genomics missed estimated earnings by 18.92%, reporting an EPS of $-0.44 versus an estimate of $-0.37.
Revenue was up $19.79 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 11.15% increase in the share price the next day.
Here's a look at 10x Genomics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.46 | -0.39 | -0.31 |
| EPS Actual | -0.15 | -0.37 | -0.57 | -0.38 |
| Revenue Estimate | 148.69M | 129.58M | 117.19M | 113.34M |
| Revenue Actual | 156.23M | 131.07M | 114.61M | 114.50M |
To track all earnings releases for 10x Genomics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
